Open AccessPreliminary results of a randomized crossover clinical trial comparing a new electromagnetic and vibrating device and alpha-blocker agents in patients affected by bladder outlet obstruction secondary to benign prostatic hyperplasia
Author(s) -
Simone Brardi,
Giuseppe Romano,
Gabriele Cevenini
Publication year - 2021
Publication title -
archivio italiano di urologia andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.429
H-Index - 23
eISSN - 2282-4197
pISSN - 1124-3562
DOI - 10.4081/aiua.2021.4.501
Subject(s) - hyperplasia , medicine , bladder outlet obstruction , urology , crossover study , benign prostatic hyperplasia (bph) , randomized controlled trial , prostate , surgery , alternative medicine , pathology , cancer , placebo
To the Editor, Benign Prostatic Hyperplasia (BPH) is one of the main causes of patients seeking urological counselling in Western countries. It has been estimated that nearly 70 percent of United States men between the ages of 60 and 69 years, and nearly 80 percent of men ≥ 70 years, have some degree of BPH [...].